Insider Transactions in Q1 2022 at Pyxis Oncology, Inc. (PYXS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Mar 31                          
            2022                          
           
         |           
        Freda C Lewis Hall | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              66,831
              +50.0%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        Connealy Pamela Yanchik CFO & COO | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              247,524
              +50.0%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        Darren S Cline | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              66,831
              +46.52%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        Mark Chin | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              66,831
              +50.0%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        Thomas Civik | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              66,831
              +50.0%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        Lara Sullivan President ,CEO & CMO | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              742,574
              +41.63%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        Jay Feingold Chief Medical Officer | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              306,930
              +46.67%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Mar 31                          
            2022                          
           
         |           
        John L Flavin | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              66,831
              +21.89%
              
         |   
        
           
              -                 
                     
         |